Search

everythinglearnresearchcommunity

for

Search:↓

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Low vitamin D levels are common in people with Alopecia Areata.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Stem cell therapy may help treat tough hair loss cases.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

The study found specific hair and scalp patterns for different types of hair loss in Koreans, noting racial differences affect diagnosis.

Mesalazine may help treat extensive alopecia areata effectively.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.